Table 2

Baseline characteristics of the study cohort

ParameterPlacebo (n=10)AIMSPRO (n=10)
Disease duration, years
 Mean (SD)10.95 (5.5)10.21 (8.5)
 Median10.97.99
 Min, Max3.7, 203, 33
mRSS
 Mean (SD)13.2 (4.7)16.9 (9.1)
 Median12.512.0
 Min, Max7, 226, 31
Autoantibodies, no. (%)
 Antitopoisomerase4 (40)2 (20)
 RNA Polymerase III3 (30)5 (50)
 Other3 (30)3 (30)
  • mRSS, modified Rodnan Skin Score.